Right. You have a cutting edge company in technology that has the best safety record ( Over Five years) in a drug that has proven meeting primary and secondary end points in a drug trials in a highly unmet needed area of CNS disease. Many people are dying do to this disease and other CNS diseases.
And what do we wait for? Someone behind a curtain in a 30 year old approval culture to approve this drug. No. I don't think so.